Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.
Socioeconomic status. The relationship with health and autoimmune diseases.
Optic Neuritis, its Differential Diagnosis and Management.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
Experience with Fingolimod in Clinical Practice.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Microwave &Magnetic (M(2)) Proteomics Reveals CNS-Specific Protein Expression Waves that Precede Clinical Symptoms of Experimental Autoimmune Encephalomyelitis.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
LSN MS guidelines for the management of multiple sclerosis.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Mitochondrial dysfunction in central nervous system white matter disorders.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.

Pages